~~<i id='1C5D00893B'><strike id='1C5D00893B'><tt id='1C5D00893B'><pre id='1C5D00893B'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：Wikipedia 2025-09-29 03:06:05 Page View：18

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： WuXi Biologics execs register to lobby as Congress comes for the company
Next article： Tori Bowie and the unacceptable rates of Black maternal death

explore

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

STAT series 'Denied by AI' wins major journalism prizes

MikeReddyforSTATDearReaders,PleasebearwithmeasIbragabouttwoofSTAT’smostaccomplished(andhumble)report

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

ThisistheonlineeditionofAdam’sBiotechScorecard,anewsubscriber-onlynewsletter.STAT+subscriberscansign